[Glitazones in type 2 diabetes--documented risks, uncertain benefits].
作者信息
Håkansson Jan
机构信息
Krokoms hälsocentral.
出版信息
Lakartidningen. 2007;104(43):3198-200.
PMID:18018937
Abstract
摘要
相似文献
1
[Glitazones in type 2 diabetes--documented risks, uncertain benefits].
Lakartidningen. 2007;104(43):3198-200.
2
[Glitazones more than hypoglycemics in type 2 diabetes].
Lakartidningen. 2007;104(43):3201-3.
3
[Glitazones critically evaluated].
Dtsch Med Wochenschr. 2007 Dec;132(49):2619. doi: 10.1055/s-2007-993106.
4
[Too positive comment on glitazones].
Ugeskr Laeger. 2007 Feb 19;169(8):733; author reply 733.
5
[Glitazones--again].
Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2707; author reply 2707.
6
[Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review].
Ugeskr Laeger. 2007 Nov 19;169(47):4054-7.
7
[The true place of glitazones in the treatment of diabetes: after the PROactive study].
Ugeskr Laeger. 2006 Jun 19;168(25):2477-9; author reply 2479-80.
8
[Don't judge all glitazones alike!].
Lakartidningen. 2007;104(43):3205.
9
The role of glitazones in management of type 2 diabetes. A dream or a nightmare?
Obes Rev. 2007 Sep;8(5):381-4. doi: 10.1111/j.1467-789X.2007.00399.x.
10
[Heart failure while taking glitazones--what do we know today?].
Dtsch Med Wochenschr. 2009 Jul;134(28-29):1488; author reply 1488. doi: 10.1055/s-0029-1225308. Epub 2009 Jul 1.
Zotero 插件